Scientific recommendations on classification of advanced therapy medicinal products

The European Medicines Agency's (EMA) Committee for Advanced Therapies (CAT) delivers scientific recommendations on whether a medicine can be classified as an advanced therapy medicinal product (ATMP). 

Update: The list of medicines that the CAT has assessed and recommended classifying as ATMPs or not since January 2021 is available below. EMA updates the list on a quarterly basis.

EMA was unable to publish ATMP classifications issued between March 2019 and December 2020 due to business continuity planning for EMA's Relocation to Amsterdam followed by the Coronavirus disease (COVID-19) pandemic, but plans to include these in the list as soon as possible.  

ATMP classifications granted before March 2019 are available separately in the archive below.


How useful was this page?

Add your rating
5 ratings
7 ratings